Last updated: May 29, 2026

Application No. 18/009,826

SARS-COV-2 IMMUNODOMINANT PEPTIDES AND USES THEREOF

Non-Final OA

Filed

Dec 12, 2022

Priority

Jun 17, 2020 — provisional 63/040,267 +5 more

Examiner

FORD, VANESSA L

Art Unit

1674

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Ahs Hospital Corp.

OA Round

1 (Non-Final)

This examiner grants 40% of cases after interview

— +38.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 212 resolved cases, 2023–2026

Examiner Intelligence

FORD, VANESSA L View full profile →

Grants 40% of resolved cases

Career Allowance Rate

85 granted / 212 resolved

-19.9% vs TC avg

Strong +38% interview lift

Without

With

+38.3%

Interview Lift

resolved cases with interview

Typical timeline

4y 1m

Avg Prosecution

25 currently pending

Career history

259

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

43.5%

+3.5% vs TC avg

§102

19.5%

-20.5% vs TC avg

§112

20.7%

-19.3% vs TC avg

Black line = Tech Center average estimate • Based on career data from 212 resolved cases

Prosecution Timeline

Dec 12, 2022

Application Filed

Mar 24, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/596,277

Patent 12630599

CA2 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION

4y 5m to grant Granted May 19, 2026

17/906,190

Patent 12595298

ANTI-NGF ANTIBODY AND ANTIGEN-BINDING FRAGMENT THEREOF, PREPARATION METHOD, AND APPLICATION THEREOF

3y 6m to grant Granted Apr 07, 2026

18/953,973

Patent 12583906

ACTRII PROTEINS AND USE IN TREATING POST-CAPILLARY PULMONARY HYPERTENSION

1y 4m to grant Granted Mar 24, 2026

10/712,335

Patent 8263325

PREDICTING, DETECTING AND MONITORING TREATMENT OF CARDIOMYOPATHIES AND MYOCARDITIS

8y 10m to grant Granted Sep 11, 2012

11/788,692

Patent 8206724

METHOD AND COMPOSITIONS FOR VACCINATION COMPRISING NUCLEIC ACID AND/OR POLYPEPTIDE SEQUENCE OF CHLAMYDIA

5y 2m to grant Granted Jun 26, 2012

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

40%

Grant Probability

78%

With Interview (+38.3%)

4y 1m (~7m remaining)

Median Time to Grant

Low

PTA Risk

Based on 212 resolved cases by this examiner. Grant probability derived from career allowance rate.